Paper7005035
Secondary prevention of myocardial infarction: a comparison of acetylsalicylic acid, placebo and phenprocoumon.
Breddin K and 4 others. Haemostasis, 1980. Cited by 93 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Secondary prevention of myocardial infarction: a comparison of acetylsalicylic acid, placebo and phenprocoumon. Papers, record 7005035. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7005035
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| 4-Hydroxycoumarins | Major topic |
| Aspirin | Major topic |
| Myocardial Infarction | Major topic |
| Phenprocoumon | Major topic |
| Aged | |
| Clinical Trials as Topic | |
| Female | |
| Hemorrhage | |
| Humans | |
| Male | |
| Middle Aged | |
| Patient Compliance | |
| Random Allocation | |
| Sex Factors | |
| Sulfinpyrazone |
Source PubMed
Cited by16
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 93 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 23,539,414 | Plasminogen activators and ischemic stroke: conditions for acute delivery. | Semin Thromb Hemost | 2013 | https://conductscience.org/library/papers/23539414 | PubMed |
| 11,406,726 | Aspirin in patients with coronary artery disease: is it simply irresistible? | J Thromb Thrombolysis | 2001 | https://conductscience.org/library/papers/11406726 | PubMed |
| 11,067,652 | Economic assessment of the secondary prevention of ischaemic events with lysine acetylsalicylate. | Pharmacoeconomics | 2000 | https://conductscience.org/library/papers/11067652 | PubMed |
| 10,211,350 | Platelets, aspirin, and cardiovascular disease. | Postgrad Med J | 1998 | https://conductscience.org/library/papers/10211350 | PubMed |
| 9,554,904 | North of England evidence based guideline development project: guideline on the use of aspirin as secondary prophylaxis for vascular disease in primary care. North of England Aspirin Guideline Development Group. | BMJ | 1998 | https://conductscience.org/library/papers/9554904 | PubMed |
| 8,471,398 | The gastrointestinal toxicity of aspirin: an overview of randomised controlled trials. | Br J Clin Pharmacol | 1993 | https://conductscience.org/library/papers/8471398 | PubMed |
| 8,298,418 | Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration. | BMJ | 1994 | https://conductscience.org/library/papers/8298418 | PubMed |
| 7,711,618 | Prophylactic aspirin and risk of peptic ulcer bleeding. | BMJ | 1995 | https://conductscience.org/library/papers/7711618 | PubMed |
| 7,106,166 | Bioavailability of acetylsalicylic acid and salicylic acid from rapid-and slow-release formulations, and in combination with dipyridamol. | Eur J Clin Pharmacol | 1982 | https://conductscience.org/library/papers/7106166 | PubMed |
| 6,865,264 | [Reversible inhibition of thrombocyte stimulation by acetylsalicylic acid and its role in antithrombotic therapy]. | Klin Wochenschr | 1983 | https://conductscience.org/library/papers/6865264 | PubMed |
| 6,716,908 | [Effects of acetylsalicylic acid on partial functions of human thrombocytes are not inhibited in vivo by salicylic acid]. | Klin Wochenschr | 1984 | https://conductscience.org/library/papers/6716908 | PubMed |
| 6,714,288 | Oral anticoagulation in patients surviving myocardial infarction. A new approach to old data. | Eur J Clin Pharmacol | 1984 | https://conductscience.org/library/papers/6714288 | PubMed |
| 3,987,774 | Plasma salicylate levels and platelet function after acute and chronic administration of slow-release acetylsalicylic acid (Monobeltin). | Eur J Clin Pharmacol | 1985 | https://conductscience.org/library/papers/3987774 | PubMed |
| 3,905,338 | Risk of haemorrhage associated with long term anticoagulant therapy. | Drugs | 1985 | https://conductscience.org/library/papers/3905338 | PubMed |
| 3,366,158 | Plasma drug and antiplatelet profiles of the original acetylsalicylic acid preparations used in the AMIS, PARIS and German-Austrian trials for secondary prevention of myocardial infarction. | Eur J Clin Pharmacol | 1988 | https://conductscience.org/library/papers/3366158 | PubMed |
| 3,125,883 | Secondary prevention of vascular disease by prolonged antiplatelet treatment. Antiplatelet Trialists' Collaboration. | Br Med J (Clin Res Ed) | 1988 | https://conductscience.org/library/papers/3125883 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7005035
GET https://conductscience.org/api/papers/v1/7005035/authors